Bionexus Gene Lab (BGLC) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Bionexus Gene Lab Corp   (NASDAQ: BGLC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Bionexus Gene Lab 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BGLC Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -96.63 %
Seq. Revenue Change 233.4 %
Revenue In Millions $0.08
Gross Profit Margin 17.05 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.01
Y / Y Gross Profit Change -96.47 %
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Bionexus Gene Lab Corp achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions recorded in the previous quarter. Revenue increased by 233.4 % Company accomplished below the average Gross Profit Margin with 17.05 %.


Observing second quarter 2026 results within Medical Laboratories industry Bionexus Gene Lab Corp has achieved highest Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
BGLC's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
64.7 % 17.79 % 0.27 %
(Dec 31 2019)   (Sep 30 2020)


BGLC Gross Income Trends • More of BGLC's Profitabilty Ratios • BGLC Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BGLC's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BGLC's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BGLC's Competitors
Gross Profit Margin Profit Margin for Bionexus Gene Lab 's Suppliers
Gross Profit Margin Profit Margin for BGLC's Customers

You may also want to know
BGLC's Annual Growth Rates BGLC's Profitability Ratios BGLC's Asset Turnover Ratio BGLC's Dividend Growth
BGLC's Roe BGLC's Valuation Ratios BGLC's Financial Strength Ratios BGLC's Gross Profit Growth
BGLC's Roa BGLC's Inventory Turnover Ratio BGLC's Growth Rates BGLC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Laboratories Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Ispecimen inc   45.18 %$ 0.069  Millions$ 0.152  Millions
Quest Diagnostics Inc  33.75 %$ 1,027.000  Millions$ 3,043.000  Millions
Aclarion Inc   32.93 %$ 0.008  Millions$ 0.025  Millions
Fulgent Genetics Inc   30.07 %$ 25.679  Millions$ 85.389  Millions
Labcorp Holdings Inc   29.80 %$ 1,112.000  Millions$ 3,731.100  Millions
Medpace Holdings Inc   28.51 %$ 201.637  Millions$ 707.331  Millions
Personalis Inc   21.21 %$ 4.743  Millions$ 22.357  Millions
Fortrea Holdings Inc   20.52 %$ 139.200  Millions$ 678.200  Millions
Bionexus Gene Lab Corp   17.05 %$ 0.013  Millions$ 0.076  Millions
American Shared Hospital Services  17.00 %$ 1.433  Millions$ 8.430  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.